Evotec SE (EVO)
1.91
-0.06
(-3.05%)
USD |
NASDAQ |
Aug 28, 16:00
1.91
0.00 (0.00%)
Pre-Market: 20:00
Evotec EPS Diluted (Quarterly) : -0.1526 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1526 |
| March 31, 2026 | -0.4017 |
| December 31, 2025 | 0.0479 |
| September 30, 2025 | -0.1417 |
| June 30, 2025 | -0.1387 |
| March 31, 2025 | -0.0936 |
| December 31, 2024 | -0.1227 |
| September 30, 2024 | -0.1228 |
| June 30, 2024 | -0.2882 |
| March 31, 2024 | -0.0633 |
| December 31, 2023 | -0.049 |
| September 30, 2023 | -0.1197 |
| June 30, 2023 | -0.0459 |
| March 31, 2023 | -0.0421 |
| December 31, 2022 | -0.0785 |
| September 30, 2022 | -0.1347 |
| June 30, 2022 | -0.0841 |
| March 31, 2022 | -0.2325 |
| December 31, 2021 | -0.102 |
| September 30, 2021 | 0.481 |
| June 30, 2021 | 0.2202 |
| March 31, 2021 | 0.1934 |
| December 31, 2020 | 0.001 |
| September 30, 2020 | -0.0055 |
| June 30, 2020 | -0.0358 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0623 |
| December 31, 2019 | 0.0291 |
| September 30, 2019 | 0.0707 |
| June 30, 2019 | -0.009 |
| March 31, 2019 | 0.0497 |
| December 31, 2018 | 0.1207 |
| September 30, 2018 | 0.1363 |
| June 30, 2018 | 0.0595 |
| March 31, 2018 | 0.0144 |
| December 31, 2017 | 0.0421 |
| September 30, 2017 | 0.0095 |
| June 30, 2017 | 0.011 |
| March 31, 2017 | 0.0266 |
| December 31, 2016 | 0.0593 |
| September 30, 2016 | 0.0392 |
| June 30, 2016 | 0.0168 |
| March 31, 2016 | -0.0055 |
| December 31, 2015 | 0.0219 |
| September 30, 2015 | -0.0111 |
| June 30, 2015 | 0.0611 |
| March 31, 2015 | -0.0055 |
| December 31, 2014 | 0.0062 |
| September 30, 2014 | -0.0196 |
| June 30, 2014 | -0.0022 |
| March 31, 2014 | -0.0205 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sartorius AG | 0.2219 |
| SCHOTT Pharma AG & Co. KGaA | 0.0749 |
| Agilent Technologies, Inc. | 1.279 |
| Bio-Rad Laboratories, Inc. | 13.85 |
| Bruker Corp. | -0.413 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -54.24M |
| Revenue (Quarterly) | 166.82M |
| Total Expenses (Quarterly) | 221.06M |
| Enterprise Value | 690.15M |
| Gross Profit Margin (Quarterly) | -1.10% |
| Profit Margin (Quarterly) | -32.51% |
| Earnings Yield | -33.93% |
| Normalized Earnings Yield | -25.04 |